Jeffrey S Mathiesen Neuroone Medical Technologies Corp (NMTC) insider trading activity

Jeffrey S Mathiesen is Director of NEUROONE MEDICAL TECHNOLOGIES Corp. Currently has a direct ownership of 114,414 shares of NMTC, which is worth approximately $124,711. The most recent transaction as insider was on Feb 14, 2025, when has been sold 27,778 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 114K

32.06% 3M change

32.06% 12M change

Total Value Held $124,711

JEFFREY S MATHIESEN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 14 2025	BUY Grant, award, or other acquisition	-	27,778 Added 19.54%	114,414 Common Stock
Mar 16 2023	BUY Grant, award, or other acquisition	-	20,576 Added 19.19%	86,636 Common Stock
May 31 2022	BUY Grant, award, or other acquisition	-	29,240 Added 30.68%	66,060 Common Stock
Jun 02 2021	BUY Grant, award, or other acquisition	-	4,592 Added 11.09%	36,811 Common Stock

Also insider at

PBLA

Panbela Therapeutics, Inc. Healthcare

Director

HSDT

HELIUS MEDICAL TECHNOLOGIES, INC. Healthcare

CFO and Treasurer

JSM